|
|
|
|
|
| Pharmacy Legal Articles |
| Title (Click for Abstract / Details) |
Author |
Issue |
Page |
View/Buy |
| PreScription: Permissible Exposure Limits and United States Pharmacopeia Chapter <800> |
Allen Loyd V Jr
|
Sep/Oct 2021 |
356 |
Buy |
| Determining Whether a Substance is Legal to Compound with Under Section 503A of the FDCA |
Cabaleiro Joe
|
Sep/Oct 2021 |
358-362 |
Buy |
| Filling the Gaps on the Institute for Safe Medication Practices (ISMP) Do Not Crush List for Immediate-release Products |
Uttaro Elizabeth, Zhao Fang, Schweighardt Anne
|
Sep/Oct 2021 |
364-371 |
Buy |
| Realities of Pharmaceutical Compounding in the Republic of Uzbekistan |
Umarov Ulugbek, Zdoryk Oleksandr, Kolisnyk Sergii, Fatkhullaeva Muyussar
|
Sep/Oct 2021 |
378-384 |
Buy |
| It's Time for a New Philosophy |
Brunner Scott
|
Sep/Oct 2021 |
386-387 |
Buy |
| Quality Control: How to Produce a Well-closed Sealed Vial in a Regulated CGMP Environment: Part 2 |
Higgins Doral (Neal) O, Prudom Melanie J, Summers Amy
|
Sep/Oct 2021 |
389-395 |
Buy |
| Expecting the Expected: Planning Considerations for Cleanroom Construction |
Roberts Patricia A, Kroon Laura
|
Jul/Aug 2021 |
276-281 |
Buy |
| Safety Aspects of Extemporaneous Prescriptions Prescribed by Latvian Healthcare Specialists |
Kiselova Olga, Maurina Baiba, Sidlovska Venta
|
Jul/Aug 2021 |
288-295 |
Buy |
| A Permanent Path for Urgent-use Compounding? APC-supported Legislation Would Allow 503As to Fill Gaps in Coverage When 503Bs Cannot |
Brunner Scott
|
Jul/Aug 2021 |
296-297 |
Buy |
| Quality Control: How to Produce a Well-closed Sealed Vial in a Regulated CGMP Environment: Part 1 |
Higgins Doral (Neal) O, Prudom Melanie J, Summers Amy
|
Jul/Aug 2021 |
298-302 |
Buy |
| FDA-funded Report on Compounded Hormones is Tainted, Analysis Shows |
Brunner Scott
|
May/Jun 2021 |
206-209 |
Buy |
| PreScription: The Past (-->2020), The Present, and The Future (2021-->) |
Allen Loyd V Jr
|
Mar/Apr 2021 |
92 |
Buy |
| Gender Bias in the Treatment of Menopausal Women: I am Hot as Hell and Not Going to Take It Anymore, Part 2 |
DeRosa Angela
|
Jan/Feb 2021 |
14-17 |
Buy |
| Reversing Erectile Dysfunction and Urinary Incontinence After Prostatectomy or Radiotherapy: The Stanley Prostate-Cancer Treatment Protocol |
McKettrick Greg, Yoch Doug
|
Jan/Feb 2021 |
18-23 |
Buy |
| Case Report: The Quest for a Palatable Compounded Metronidazole (Base) Suspension |
McElhiney Linda F
|
Jan/Feb 2021 |
24-28 |
Buy |
| Formulation and Pharmaceutical Evaluation of Extemporaneous α-arbutin Creams for the Treatment of Melasma |
Teeranachaideekul Veerawat, Boonsongsawat Worrawee, Asanawittaya Waralee, Jintapattanakit Anchalee, Chantasart Doungdaw, Wongrakpanich Amaraporn
|
Jan/Feb 2021 |
62-72 |
Buy |
| PreScription: The NASEM cBHT Report, Part 1 |
Allen Loyd V Jr
|
Nov/Dec 2020 |
444 |
Buy |
| NASEM Report on Compounded Topical Pain Creams |
Allen Loyd V Jr
|
Nov/Dec 2020 |
446-448 |
Buy |
| Safety Standards in Pharmaceutical Compounding, Part 3: Fire Safety |
Allen W Chris, Greeson Nicole MH, Mixon William
|
Nov/Dec 2020 |
451-458 |
Buy |
| Gender Bias in the Treatment of Menopausal Women: I am Hot as Hell and Not Going to Take It Anymore, Part 1 |
DeRosa Angela
|
Nov/Dec 2020 |
466-470 |
Buy |
| Safety and Efficacy Studies, Pharmacy Education, and the NASEM Report on Compounded Topical Pain Creams |
Allen Loyd V Jr
|
Sep/Oct 2020 |
356 |
Buy |
| Safety Standards in Pharmaceutical Compounding, Part 2: A Closer Look at Agency Information, Oversight, and Assistance |
Greeson Nicole MH, Mixon William, Allan W Chris
|
Sep/Oct 2020 |
371-379 |
Buy |
| An Unconscionable, Unnecessary Fight |
Bruner Scott
|
Sep/Oct 2020 |
386-387 |
Buy |
| PreScription: COVID-19 and Compounding Pharmacists |
Allen Loyd V Jr
|
Jul/Aug 2020 |
268 |
Buy |
| Safety Standards in Pharmaceutical Compounding, Part 1: The Occupational Safety and Health Administration |
Greeson Nicole MH, Mixon William, Allan W Chris
|
Jul/Aug 2020 |
270-276 |
Buy |
| Finally: A Final U.S. Food and Drug Administration Memorandum of Understanding, but It's Flawed |
Brunner Scott
|
Jul/Aug 2020 |
296-297 |
Buy |
| Incorporating Quality Assurance in Pharmaceutical Compounding-related Courses in the PharmD Curricula |
Hossain Mohammad Faisal, Levesque Dan, Frye John, Rashid Mamoon
|
Jul/Aug 2020 |
322-326 |
Buy |
| U.S. Food and Drug Administration Takes Aim (Again) at Animal Compounding: Draft Guidance for Industry #256 Lacks Authority, Will Increase Costs, and Put Pets at Risk |
Brunner Scott
|
May/Jun 2020 |
198-199 |
Buy |
| PreScription: Formal Appeals to United States Pharmacopeia Regarding USP Chapters <795>,<797>, and <825>: Part 1 |
Allen Loyd V Jr
|
Mar/Apr 2020 |
92 |
Buy |
| A "North Star" for Pharmacy Compounders |
Brunner Scott
|
Mar/Apr 2020 |
110-113 |
Buy |
| PreScription: One Size Does Not Fit All! |
Allen Loyd V Jr
|
Jan/Feb 2020 |
4 |
Buy |
| How to Qualify Container Closure Systems for Intended Use, Part 2: Choosing the Right Components for Container Closure Systems |
Vaughn Stacey R, Radwick Allison
|
Jan/Feb 2020 |
14-19 |
Buy |
| Performing a United States Pharmacopeia Chapter <800> Compliant Assessment of Risk |
Cabaleiro Joe
|
Jan/Feb 2020 |
21-27 |
Buy |
| New and Improved! |
Brunner Scott
|
Jan/Feb 2020 |
28-29 |
Buy |
| Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs |
Dillon L R
|
Jan/Feb 2020 |
30-36 |
Buy |
| PreScription: As Things Change…. |
Allen Loyd V Jr
|
Nov/Dec 2019 |
444 |
Buy |
| How to Qualify Container Closure Systems for Intended Use, Part 1 |
Kim Amy A, Gehrmann Matthew R, McCaw James, McAndrew T Page
|
Nov/Dec 2019 |
454-461 |
Buy |
| Are You Part of the Solution or Part of the Problem? |
Brunner Scott
|
Nov/Dec 2019 |
462-464 |
Buy |
| PreScription: Regulations, Laws, Standards, Guidelines, Procedures, Etc |
Allen Loyd V Jr
|
Sep/Oct 2019 |
356 |
Buy |
| Threading the Needle |
Brunner Scott
|
Sep/Oct 2019 |
383-385 |
Buy |
| Now Is the Time for All Good Compounders to Come to the Aid of Their Profession: What You Do Right Now to Advance Compounding's Advocacy Priorities Can Help Assure Your Profession's Future |
Brunner Scott
|
Jul/Aug 2019 |
294-296 |
Buy |
| How to Develop and Maintain a Hazardous Drug List |
Dillon L Rad
|
May/Jun 2019 |
182-186 |
Buy |
| Can We Fix It? |
Brunner Scott
|
May/Jun 2019 |
208-209 |
Buy |
| PreScription: Compounding with Cannabidiol |
Allen Loyd V Jr
|
Mar/Apr 2019 |
92 |
Buy |
| Nimodipine Compounded Oral Suspension: A True Documented Medical Need |
McElhiney Linda F
|
Mar/Apr 2019 |
106-111 |
Buy |
| Patient Access Is a Patient Safety Issue |
Pore David
|
Mar/Apr 2019 |
120-121 |
Buy |
| Basics of Compounding: Summary of the Official United States Pharmacopeia Monographs for Compounded Preparations |
Allen Loyd V Jr
|
Mar/Apr 2019 |
135-143 |
Buy |
| An Outlook on the European and Italian Rules to Guarantee Magistral Formulas |
Selmin Francesca, Casiraghi Antonella, Musazzi Umberto M, Fortini Marco, Minghetti Paola
|
Jan/Feb 2019 |
6-12 |
Buy |
| U.S. Food and Drug Administration Inspection Authority: How to Know Whether U.S. Food and Drug Administration Inspectors Are Crossing the Line |
Snow Stephen T, Stannard Robert W, Bellis Jennifer, Moss Carrie A
|
Jan/Feb 2019 |
32-33 |
Buy |
| Basics of Compounding: Standardization of Compounded Medications |
Allen Loyd V Jr
|
Jan/Feb 2019 |
35-44 |
Buy |
| Quality Control and Basics of Sterile Compounding: Attempting to Avoid Out-of-Specification Results and Patient Harm in Sterile Compounding |
Martin Matt
|
Jan/Feb 2019 |
47-49 |
Buy |
| Basics of Sterile Compounding. Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 2
|
Martin Matt
|
Nov/Dec 2018 |
475-478 |
Buy |
| PreScription: Updating Formulations |
Allen Loyd V Jr
|
Sep/Oct 2018 |
356 |
Buy |
| Current Trends and Emerging Priorities in Compounded Preparations for Children |
Parrish Richard H II
|
Sep/Oct 2018 |
358-366 |
Buy |
| Certification of Powder-containment Hoods for Nonsterile Compounding |
Mulder Kyle, Dozzi Raphael
|
Sep/Oct 2018 |
369-384 |
Buy |
| Compounding Enclosures: Ensuring Safety During the Preparation of Sterile and Nonsterile Formulations |
Ashe Krystina, Baskett Dustin
|
Sep/Oct 2018 |
387-398 |
Buy |
| Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 1 |
Martin Matt
|
Sep/Oct 2018 |
401-404 |
Buy |
| Your Presence is Needed at Compounders on Capitol Hill! |
Blankenship Cynthia
|
May/Jun 2018 |
204-205 |
Buy |
| PreScription: Drug Quality and Security Act Implementation Subcommittee Hearing |
Allen Loyd V Jr
|
Mar/Apr 2018 |
92 |
Buy |
| Personalized Medicine and Customized Drug Delivery Systems: The New Trend of Drug Delivery and Disease Management |
Soni Abhishek, Gowthamarajan Kuppusamy, Radhakrishnan Arun
|
Mar/Apr 2018 |
108-121 |
Buy |
| IACP Legislative/Regulatory Update: The International Academy of Compounding Pharmacists Testifies at U.S. House of Representatives' Energy & Commerce Health Subcommittee Pharmacy Compounding Hearing |
Blankenship Cynthia
|
Mar/Apr 2018 |
125-126 |
Buy |
| Quality Control: Lessons Learned from a Trimix Stability Study in a 503A Compounding Pharmacy |
Rhoads Rick
|
Mar/Apr 2018 |
129-134 |
Buy |
| PreScription: 2017--Some Good Things Happened and Some Others |
Allen Loyd V Jr
|
Jan/Feb 2018 |
4 |
Buy |
| Certification, Accreditation, and Credentialing for 503A Compounding Pharmacies |
Pritchett Jon, McCrory Gary, Kraemer Cheri, Jensen Brenda, Allen Loyd V Jr
|
Jan/Feb 2018 |
7-16 |
Buy |
| The International Academy of Compounding Pharmacists: Government Affairs Lookback on 2017 Accomplishments and Look Ahead at 2018 Initiatives |
Blankenship Cynthia
|
Jan/Feb 2018 |
26-28 |
Buy |
| PreScription: Issues with the NAMS 2017 Hormone Therapy Position Statement |
Allen Loyd V Jr
|
Nov/Dec 2017 |
444 |
Buy |
| Join the Partnership for Personalized Prescriptions (P3) Advocacy Effort! |
Blankenship Cynthia
|
Nov/Dec 2017 |
468 |
Buy |
| Validation of the Technological Process of the Preparation "Milk by Vidal" |
Savchenko LP, Mishchenko VA, Georgiyants VA
|
Nov/Dec 2017 |
513-517 |
Buy |
| PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs |
Allen Loyd V Jr
|
Sep/Oct 2017 |
356 |
Buy |
| Child-safety Containers/Devices and Compounding |
Allen Loyd V Jr
|
Sep/Oct 2017 |
364-370 |
Buy |
| Documentation: Records and Reports |
Akers Michael J
|
Sep/Oct 2017 |
373-380 |
Buy |
| IACP Legislative/Regulatory Update |
International Academy of Compounding Pharmacists
|
Sep/Oct 2017 |
382-383 |
Buy |
| The International Academy of Compounding Pharmacists Applauds the Leadership of Congressmen Griffith and Cuellar in Introducing Bill HR 2871 |
Rice Baylor
|
Jul/Aug 2017 |
290-291 |
Buy |
| PreScription: United States Pharmacopeia Chapter <800> Comments and Alternatives |
Allen Loyd V Jr
|
May/Jun 2017 |
180 |
Buy |
| International Academy of Compounding Pharmacists Legislative/Regulatory Update |
Rice Baylor
|
May/Jun 2017 |
212-213 |
Buy |
| PreScription: Whatever Happened to Common Sense? |
Allen Loyd V Jr
|
Mar/Apr 2017 |
92 |
Buy |
| U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies |
Yoch Doug
|
Mar/Apr 2017 |
95-102 |
Buy |
| The International Academy of Compounding Pharmacists Introduces a New President |
Rice Baylor
|
Mar/Apr 2017 |
116-117 |
Buy |
| Quality Control: (Material) Safety Data Sheets |
Allen Loyd V Jr
|
Mar/Apr 2017 |
118-124 |
Buy |
| Basics of Compounding: 3D Printing--Pharmacy Applications, Part 1 |
Allen Loyd V Jr
|
Mar/Apr 2017 |
127-130 |
Buy |
| PreScription: Compounding Pharmacy Issues for 2017 |
Allen Loyd V Jr
|
Jan/Feb 2017 |
4 |
Buy |
| When to Compound Medications for Veterinary Patients |
Forsythe Lauren Eichstadt
|
Jan/Feb 2017 |
19-21 |
Buy |
| Why You Should Become an International Academy of Compounding Pharmacists Member |
Gates Ernest P Jr
|
Jan/Feb 2017 |
28 |
Buy |
| U.S. Food and Drug Administration List of Drugs NOT to be Used in Compounded Medications for Humans (The Negative List) |
|
Nov/Dec 2016 |
457-458 |
Buy |
| The "Lists": What Do They Mean? |
Voliva John
|
Nov/Dec 2016 |
477-479 |
Buy |
| Basics of Compounding: Clinical Pharmaceutics, Part 2 |
Allen Loyd V Jr
|
Nov/Dec 2016 |
485-493 |
Buy |
| PreScription: Stability Studies and United States Pharmacopeia-National Formulary-Grade Chemicals |
Allen Loyd V Jr
|
Sep/Oct 2016 |
356 |
Buy |
| Pharmaceutical Compounding: The Oldest, Most Symbolic, and Still Vital Part of Pharmacy |
Kochanowska-Karamyan Anna J
|
Sep/Oct 2016 |
367-374 |
Buy |
| More than 300 Attendees Convene in Washington, DC, for the 22nd Annual Compounders on Capitol Hill: The United Voice of Compounders is Heard! |
Voliva John
|
Sep/Oct 2016 |
377-378 |
Buy |
| Compounding Transdermal Medication for Feline Patients |
Eichstadt Lauren R
|
Jul/Aug 2016 |
271-274 |
Buy |
| IACP's 2016 Compounders on Capitol Hill Asks |
|
Jul/Aug 2016 |
294-296 |
Buy |
| Basics of Sterile Compounding: Personnel Requirements for Sterile Compounding |
Akers Michael J
|
Jul/Aug 2016 |
307-314 |
Buy |
| Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines |
Allen Loyd V Jr
|
Jul/Aug 2016 |
351 |
View Sample |
| PreScription: Patient Access to Pharmaceuticals |
Allen Loyd V Jr
|
May/Jun 2016 |
180 |
Buy |
| Compounding in Nigeria |
Alfred-Ugbenbo Deghinmotei, Zdoryk Oleksandr A, Georgiyants Victoriya A, Schnatz Rick
|
May/Jun 2016 |
189-192 |
Buy |
| IACP Names Voliva Executive Vice President |
McCrory Gary
|
May/Jun 2016 |
194 |
Buy |
| PreScription: Compounding: A Changing Paradigm |
Allen Loyd V Jr
|
Mar/Apr 2016 |
92 |
Buy |
| Legislative/Regulatory Update: From the International Academy of Compounding Pharmacists: Appropriations |
McCrory Gary
|
Mar/Apr 2016 |
95-96 |
Buy |
| Microbial Identification in Pharmaceutical Compounding |
Hyde Tiffany, Anstead James, Schade Lisa, Zellner James
|
Jan/Feb 2016 |
13-18 |
Buy |
| Performance Improvement in 503A Compounding Pharmacies: A Plan for Assessment, Implementation, and Sustained Success |
Pritchett Jon, Mixon William, O'Connell Kevin
|
Jan/Feb 2016 |
29-36 |
Buy |
| PostScription: The Home Field Advantage |
Cabaleiro Joe
|
Jan/Feb 2016 |
86-87 |
Buy |
| PreScription: The Documented Past and the Exciting Future |
Allen Loyd V Jr
|
Nov/Dec 2015 |
442 |
Buy |
| International Academy of Compounding Pharmacists' Legislative Regulatory Update: Take Action! Stop the U.S. Good and Drug Administration's Misguided Veterminary Guidance |
Miller David G
|
Nov/Dec 2015 |
449-450 |
Buy |
| Applying Quality of Design Concepts to Pharmacy Compounding |
Timko Robert J
|
Nov/Dec 2015 |
453-463 |
Buy |
| U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs |
Allen Loyd V Jr
|
Nov/Dec 2015 |
487-488 |
Buy |
| The International Academy of Compounding Pharmacists Comments to the Draft Memorandum of Understanding |
Miller David G
|
Sep/Oct 2015 |
375 |
Buy |
| The Evolution of 21 CFR Parts 210 & 211 for Drug Compounders: An Unspoken Opportunity for Pharmacists |
Parks Kenneth Chase, Bernard Brian, Cogdill Christopher Blake
|
Sep/Oct 2015 |
377-380 |
Buy |
| Nominations of Difficult to Compound Drugs to the U.S. Food and Drug Administration--Pharmacy Compounding Advisory Committee: Part 1 |
Allen Loyd V Jr
|
Sep/Oct 2015 |
389-390 |
Buy |
| PostScription: Progress Report: Provider Status Continues to Gain Strength! |
Menighan Thomas E
|
Sep/Oct 2015 |
437 |
Buy |
| PreScription: Potpourri of Opinions…From Many |
Allen Loyd V
|
Jul/Aug 2015 |
266 |
Buy |
| U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances |
Miller David G
|
Jul/Aug 2015 |
303-305 |
Buy |
| Basics of Compounding: The "Negative" List |
Allen Loyd V
|
Jul/Aug 2015 |
311-313 |
Buy |
| IACP Says: "Fix DQSA" |
Miller David
|
May/Jun 2015 |
212 |
Buy |
| Quality Assurance and Quality Control, Part 2 |
Akers Michael J
|
May/Jun 2015 |
215-221 |
Buy |
| PostScription: Opportunities to Change the Pharmacy Landscape |
Menighan Thomas E
|
May/Jun 2015 |
271 |
Buy |
| New England Compounding Center Indictment |
Cabaleiro Joe
|
Mar/Apr 2015 |
94-102 |
Buy |
| Standing Together Fixing the Drug Quality and Security Act |
Miller David G
|
Mar/Apr 2015 |
104-106 |
Buy |
| Standarized Compounding: The Importance of Doing it the Same Way Every Time |
Dillon L Rad
|
Mar/Apr 2015 |
109-112 |
Buy |
| PreScription: 2014 in Review |
Allen Loyd V Jr
|
Jan/Feb 2015 |
4 |
Buy |
| Agar Transfer Devices for Environmental Sampling in the Compounding Pharmacy: Science and Compliance |
Grilli Anthony, Sutton Scott
|
Jan/Feb 2015 |
30-37 |
Buy |
| Basics of Sterile Compounding: Aseptic Processing |
Akers Michael J
|
Jan/Feb 2015 |
49-56 |
Buy |
| Basics of Compounding: The Revised "Not to Compound List" |
Allen Loyd V Jr
|
Jan/Feb 2015 |
57-58 |
Buy |
| PostScription: Pharmacists Advancing Toward Provider Status |
Menighan Thomas E
|
Jan/Feb 2015 |
86-87 |
Buy |
| Compounding Legislation: Focus Shifts to States |
Miller David G
|
Nov/Dec 2014 |
470-472 |
Buy |
| PostScription: Pharmacy Compounding Accreditation Board: Past, Present, and Future |
Cabaleiro Joe
|
Nov/Dec 2014 |
526-527 |
Buy |
| Final Guidance for Pharmacy Compounding of Human Drug Products Under Section 503A |
Blankenship Cynthia E
|
Sep/Oct 2014 |
379-380 |
Buy |
| Compounding Practices in a Portuguese Community Pharmacy |
Reis Maria, Carvalho Maria, Rodrigues Angelo
|
Sep/Oct 2014 |
392-395 |
Buy |
| PostScription: The Future of Veterinary Compounding |
Jordan Dinah G
|
Sep/Oct 2014 |
438-439 |
Buy |
| PreScription: Challenging Times |
Allen Loyd V Jr
|
Jul/Aug 2014 |
268 |
Buy |
| Vial Washers for the Compounding Pharmacy: Ensuring Preparation Safety |
Johnson Kain, Sully Andrew, Anthenat Bruce
|
Jul/Aug 2014 |
270-276 |
Buy |
| Color Additives: Legislative Perspective in the United States, Europe, Australia, and India |
Kumar Anuj, Madan Anil K
|
Jul/Aug 2014 |
293-300 |
Buy |
| 400 Attendees Convene in Washington, D.C., for the 20th Annual Compounders on Capitol Hill |
Miller David G
|
Jul/Aug 2014 |
302 |
Buy |
| Quality Control: Microbial Limit Tests for Nonsterile Pharmaceuticals, Part 2 |
Vu Nicole, Lou Jessica R, Kupiec Thomas C
|
Jul/Aug 2014 |
305-310 |
Buy |
| PreScription: Déjà Vu All Over Again |
Allen Loyd V Jr
|
May/Jun 2014 |
180 |
Buy |
| The U.S. Food and Drug Administration Responds to the International Academy of Compounding Pharmacists' Outsourcing Letter |
Miller David G
|
May/Jun 2014 |
208 |
Buy |
| PreScription: Standards vs Opinions |
Allen Loyd V Jr
|
Mar/Apr 2014 |
92 |
Buy |
| Pharmaceutical Compounding or Pharmaceutical Manufacturing? A Regulatory Perspective |
Timko Robert J, Crooker Philip EM
|
Mar/Apr 2014 |
101-111 |
Buy |
| Compounding Practices in Iran |
Goodarzi Navid, Niknam Somayeh, Akbarzadeh Tahmineh, Gholami Kheirollah
|
Mar/Apr 2014 |
112-116 |
Buy |
| IACP's Continuing Support of Compounding Pharmacists: Letter to the FDA Concerning 503B Outsourcing Facilities |
Miller David G
|
Mar/Apr 2014 |
117-118 |
Buy |
| PreScription: The International Journal of Pharmaceutical Compounding Begins Its 18th Year |
Allen Loyd V Jr
|
Jan/Feb 2014 |
4 |
Buy |
| Good Enough for America |
Worthen Dennis B
|
Jan/Feb 2014 |
20-29 |
Buy |
| U.S. Food and Drug Administration Requests for Input on HR 3204 Enactment: The Drug Quality and Security Act of 2013 |
Miller David G
|
Jan/Feb 2014 |
35-36 |
Buy |
| Physicians, Pharmacists, and the Importance of Quality Pharmacy Compounding |
Allen Loyd V Jr
|
Nov/Dec 2013 |
477-479 |
Buy |
| HR 3204 -- The Drug Quality and Security Act: What Does It Say? What Does It Mean? What Happens Now? |
Miller David G
|
Nov/Dec 2013 |
480-481 |
Buy |
| Quality Control Analytical Methods: A Growing Codependency: Compounding Pharmacy and Safety |
Prince Bryan, Lundeval Jeremy
|
Nov/Dec 2013 |
485-489 |
Buy |
| PreScription: GMPs vs. GCPs: Manufacturing and Compounding Definitions |
Allen Loyd V Jr
|
Sep/Oct 2013 |
356 |
Buy |
| Compounding Pharmacies: Before and After an Inspection |
Kulkarni Darshan, Ricketts Samantha
|
Sep/Oct 2013 |
358-362 |
Buy |
| Preventing Medication Errors with Nimodipine by Compounding Proper Dosage Forms |
McElhiney Linda F
|
Sep/Oct 2013 |
364-368 |
Buy |
| 2013 State Compounding Legislation Tracker Updated: August 12, 2013 |
Miller David G
|
Sep/Oct 2013 |
375-378 |
Buy |
| PostScription: GMPs vs. GCPs: United States Pharmacopeia General Chapters |
Allen Loyd V Jr
|
Sep/Oct 2013 |
439 |
Buy |
| United States Pharmacopeia Chapter <797> Timeline: 1989 to 2013 |
Newton David W
|
Jul/Aug 2013 |
283-288 |
Buy |
| Pharmacists' Liability: What My Pharmacy Law Professor Did Not Cover |
Rizo Mike
|
Jul/Aug 2013 |
290-293 |
Buy |
| International Academy of Compounding Pharmacists Legislative/Regulatory Update |
Miller David G
|
Jul/Aug 2013 |
302-304 |
Buy |
| PostScription: Traditional vs Nontraditional Pharmacy |
Allen Loyd V Jr
|
Jul/Aug 2013 |
351 |
Buy |
| PreScription: Compounding for Drug Shortages |
Allen Loyd V Jr
|
May/Jun 2013 |
180 |
Buy |
| Complying with Occupational Safety and Health Administration Regulations: A Guide for Compounding Pharmacists |
Mixon Bill, Nain John
|
May/Jun 2013 |
182-190 |
Buy |
| Decontamination Technology: The Missing Element |
Rahe Hank
|
May/Jun 2013 |
193-199 |
Buy |
| International Academy of Compounding Pharmacists' Legislative/Regulatory Update |
Miller David G
|
May/Jun 2013 |
206 |
Buy |
| Quality Control Analytical Methods: A Summarized Discussion of Current Good Manufacturing Practice Regulations |
Allen Loyd V Jr
|
May/Jun 2013 |
210-219 |
Buy |
| Assessing the Stability of Common Radiopharmaceuticals Compounded and Utilized Outside Package Insert Guidelines |
Weatherman Kara D, Augustine Samuel, Christoff Jeffrey, Galbraith Wendy
|
May/Jun 2013 |
238-246 |
Buy |
| PreScription: Pharmacy Committees |
Allen Loyd V Jr
|
Mar/Apr 2013 |
92 |
Buy |
| Compounding in Ukraine |
Zdoryk Oleksandr A, Georgiyants Victoriya A, Gryzodub Oleksandr I, Schnatz Rick
|
Mar/Apr 2013 |
124-127 |
Buy |
| International Academy of Compounding Pharmacists Legislative/Regulatory Update |
Miller David G
|
Mar/Apr 2013 |
128 |
Buy |
| PreScription: Looking for Solutions |
Menighan Thomas E
|
Jan/Feb 2013 |
4 |
Buy |
| Pediatric Health Care: An Introduction |
Williams LaVonn A
|
Jan/Feb 2013 |
6-8 |
Buy |
| International Academy of Compounding Pharmacists' Recommendations for State-based Legislative and Regulatory Initiatives |
Miller David G
|
Jan/Feb 2013 |
48-49 |
Buy |
| PostScription: GMPs and GCPs: A Topical Comparison |
Allen Loyd V Jr
|
Jan/Feb 2013 |
87 |
Buy |
| The Drug Enforcement Agency's Position on "Constructive Transfer" Under the Controlled Substances Act |
Pore R David
|
Nov/Dec 2012 |
446-450 |
Buy |
| Drug Shortage Compounding: The Only Safe Medication Source in a Time of Crisis |
Lyon Joanna
|
Nov/Dec 2012 |
456-460 |
Buy |
| Legislative/Regulatory Update from the International Academy of Compounding Pharmacists |
Miller David G
|
Nov/Dec 2012 |
476-478 |
Buy |
| Quality Control: Analytical Methods. Certificates of Analysis, Part 1 |
Allen Loyd V Jr
|
Nov/Dec 2012 |
486-488 |
Buy |
| Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 5: Outsourcing and Responsible Personnel |
Allen Loyd V Jr
|
Nov/Dec 2012 |
490-496 |
Buy |
| Legislative/Regulatory Update from the International Academy of Compounding Pharmacists |
Miller David G
|
Sep/Oct 2012 |
382-384 |
Buy |
| Drug Shortages & Discontinued Drugs: The Effects on Patients and Healthcare Providers |
Allen Loyd V Jr, Williams LaVonn A
|
Jul/Aug 2012 |
294-298 |
Buy |
| Legislative/Regulatory Update from the International Academy of Compounding Pharmacists |
Miller David G
|
Jul/Aug 2012 |
300-302 |
View Sample |
| Selection of Color Additives: A Regulatory View |
Kumar Anuj, Dureja Harish, Madan Anil K
|
Jul/Aug 2012 |
304-309 |
Buy |
| PreScription: You're On Your Own |
Allen Loyd V Jr
|
May/Jun 2012 |
180 |
Buy |
| PreScription: Working in Handcuffs |
Menighan Thomas E
|
May/Jun 2012 |
180 |
Buy |
| Legislative/Regulatory Update from the International Academy of Compounding Pharmacists |
Miller David G
|
May/Jun 2012 |
220-222 |
View Sample |
| Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 2: Documentation and Verification |
Allen Loyd V Jr
|
May/Jun 2012 |
230-234 |
Buy |
| The International Academy of Compounding Pharmacists Stepping Up Efforts to Remedy Problems Caused by the U.S. Drug Enforcement Administration's "Constructive Transfer" Policy |
Miller David G
|
Mar/Apr 2012 |
94-96 |
View Sample |
| Brazilian National System for the Monitoring and Improvement of Compounding Practices: Program Outcomes |
Guedes de Souza Hugo, Favaro Alvaro Jr, Andrade Alba Livia, Gomes Lenir Yago, do Carmo Garcez Maria
|
Mar/Apr 2012 |
98-102 |
Buy |
| PostScription: Best Practice Recommendations for Compounding 17-Hydroxyprogesterone |
Cabaleiro Joe
|
Jan/Feb 2012 |
86-87 |
Buy |
| Legislative/Regulatory Update from the International Academy of Compounding Pharmacists |
Miller David G
|
Jan/Feb 2012 |
50-52 |
View Sample |
| PreScription: Compounding: Keeping Elephants Our of Our Mouseholes |
Menighan Thomas E
|
Nov/Dec 2011 |
444 |
Buy |
| Legislative/Regulatory Update from the International Academy of Compounding Pharmacists |
Miller David G
|
Nov/Dec 2011 |
471-472 |
View Sample |
| The International Academy of Compounding Pharmacists Debuts the Compounding Pharmacy Assessment Questionnaire |
Miller David G
|
Nov/Dec 2011 |
474-479 |
View Sample |
| PostScription: Drug Disposal: Compounding Pharmacists' Involvement in the Prevention of Prescription Drug Misuse and Abuse |
Williams LaVonn A
|
Nov/Dec 2011 |
526-527 |
Buy |
| PreScription: Third-party Inequities and Discrimination |
Allen Loyd V Jr
|
Sep/Oct 2011 |
356 |
Buy |
| Natural Tragedies: Planning for Disasters and Emergencies |
Williams LaVonn A
|
Sep/Oct 2011 |
368-371 |
Buy |
| Legislative/Regulatory Update from the International Academy of Compounding Pharmacists |
Miller David
|
Sep/Oct 2011 |
382-384 |
Buy |
| Basics of Compounding: Implementing United States Pharmacopeia Chapter <795> Pharmaceutical Compounding--Nonsterile Preparations, Part 2 |
Allen Loyd V Jr
|
Sep/Oct 2011 |
408-414 |
Buy |
| Waterless Alcohol-based Hand Sanitizers for the Compounding Pharmacy |
Mixon William, Wood Adam P, Low Jennifer, Homan Linda
|
Jul/Aug 2011 |
278-284 |
Buy |
| Legislative/Regulatory Update from the International Academy of Compounding Pharmacists |
Miller David
|
Jul/Aug 2011 |
286-288 |
Buy |
| PreScription: Greed Does Not Pay! Makena, Lucentis, and Others |
Allen Loyd V Jr
|
May/Jun 2011 |
180 |
Buy |
| PreScription: Making Things Right--Or Not? |
Menighan Thomas E
|
May/Jun 2011 |
180 |
Buy |
| Legislative/Regulatory Update from the International Academy of Compounding Pharmacists |
Miller David
|
May/Jun 2011 |
218-221 |
Buy |
| Quality Control Analytical Methods: Aqua Pura: Water Purification Systems and United States Pharmacopeia Waters for the Compounding Pharmacy, Part 2: USP Waters: Experts at the United States Pharmacopeia Answer Compounders' Questions |
Schnatz Rick, Hernandex-Cardoso Antonio
|
May/Jun 2011 |
224-232 |
Buy |
| PreScription: Discontinued Drugs and Drug Shortages |
Allen Loyd V Jr
|
Mar/Apr 2011 |
92 |
Buy |
| PreScription: Compounding with Manufactured Products |
Allen Loyd V Jr
|
Nov/Dec 2010 |
448 |
Buy |
| Home Infusion: Overcoming the Barriers to Entry |
Franklin David M
|
Nov/Dec 2010 |
450-455 |
Buy |
| PreScription: Compounding Veterinary Products: Needed but Problematic |
Menighan Thomas E
|
Sep/Oct 2010 |
358 |
Buy |
| Home Infusion Accreditation: Another Quality Recognition Branding Tool |
Canally Sandra C
|
Sep/Oct 2010 |
360-364 |
Buy |
| PreScription: Beginning of a New United States Pharmacopeial Convention, Inc., Cycle |
Allen Loyd V Jr
|
Jul/Aug 2010 |
268 |
Buy |
| PreScription: Sterile Product Outsourcing: Growing Trend in Hospitals |
Menighan Thomas E
|
Jul/Aug 2010 |
268 |
Buy |
| PreScription: Healthcare Reform Is Not All That Is Happening in Washington |
Menighan Thomas E
|
May/Jun 2010 |
180 |
Buy |
| PostScription: Healthcare Reform and Compounding Issues |
Levesque Paul T
|
May/Jun 2010 |
262-263 |
Buy |
| Cop's Best Friend: Preventing the Illegal Distribution and Transportation of Prescription Drugs |
Burke John, Hill Jeff
|
Mar/Apr 2010 |
131-133 |
Buy |
| PostScription: Is Being Involved in the Pharmacy Student Preceptor Program Worth the Effort? |
Allen Loyd V Jr, Burger Mark
|
Mar/Apr 2010 |
174-175 |
Buy |
| Setting Up a National System of Compounding Pharmacies: Preventing Error, Assuring Quality, Building Trust |
Guedes de Souza Hugo, Favaro Alvaro Jr, Andrade Alba Livia, Gomes Lenir Yago, de Souza Aguiar Simone, do Carmo Garcez Maria
|
Nov/Dec 2009 |
532-536 |
Buy |
| An Overview of United States Pharmacopeia Chapter <795> and American Society of Health-System Pharmacists Guidelines for Nonsterile Compounding |
McElhiney Linda F
|
Nov/Dec 2009 |
525-530 |
Buy |
| Efforts to Combat Prescription Drug Abuse Should Not Limit Access to Compounded Pain Medications |
Gilbert John A
|
Sep/Oct 2009 |
400-403 |
Buy |
| PostScription: Setting up a National System of Compounding Pharmacies: An Introduction |
Guedes de Souza Hugo, Favaro Alvaro Jr, Andrade Alba Livia, Gomes Lenir Yago, de Souza Aguiar Simone, do Carmo Garcez Maria
|
Sep/Oct 2009 |
447 |
Buy |
| PostScription: Compounding Pharmacy in Puerto Rico |
Lopez Marisol
|
Jul/Aug 2009 |
350-351 |
Buy |
| PreScription: Electronic Prescribing |
Allen Loyd V Jr
|
Mar/Apr 2009 |
92 |
Buy |
| PostScription: Compounding in Argentina |
Naddeo Aldo Mario
|
Mar/Apr 2009 |
175 |
Buy |
| PreScription: A New Start: What Will 2009 Bring? |
Allen Loyd V Jr
|
Jan/Feb 2009 |
4 |
Buy |
| PostScription: The Compounding Pharmacy in Brazil: A Pharmacist's Perspective |
Guedes de Souza Hugo, do Carmo Garcez Maria, Pinheiro Vanessa A
|
Jan/Feb 2009 |
87-88 |
Buy |
| Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 11: Hazardous Drugs |
Allen Loyd V Jr, Okeke Claudia C
|
Jan/Feb 2009 |
56-62 |
Buy |
| The Value of Near Infrared Spectroscopy in a Small Hospital Compounding Unit to Control the Risks Associated with Raw Materials |
Storme-Paris Isabelle, Storme Thomas, Thauvin Maxime, Brion Francoise, Chaminade Pierre, Rieutord Andre
|
Jan/Feb 2009 |
81-86 |
Buy |
| Publication Expansion of United States Pharmacopeial Convention's Veterinary Standards and Clinical Information |
Neal Amy S, DeVeau Ian, Schnatz Rick G
|
Sep/Oct 2008 |
405-409 |
Buy |
| Golden Ticket to the United States Pharmacopeial Convention's Veterinary Internship |
Kirk Loren Madden
|
Sep/Oct 2008 |
410-413 |
Buy |
| Medication Therapy Management Implementation, Part 2: Study Methodologies, Barriers, and Recommendations to Overcome Barriers |
Fyke Jeremy P, Yale Robert N, Corbett Corinne, Litera Natalie
|
Sep/Oct 2008 |
414-418 |
Buy |
| Insurance for the Compounding Pharmacy Business, Part 1: Who Is Covered? |
Baker Kenneth R
|
Sep/Oct 2008 |
420-424 |
Buy |
| Prescription: Is "Globalization" a Good Idea? |
Allen Loyd V Jr
|
Nov/Dec 2008 |
474 |
Buy |
| Medication Therapy Management Implementation, Part 3: Barriers and Recommendations to Overcome Barriers |
Fyke Jeremy P, Yale Robert N, Corbett Corinne, Litera Natalie
|
Nov/Dec 2008 |
508-513 |
Buy |
| Insurance for the Compounding Pharmacy Business, Part 2: What, When, and Where |
Baker Kenneth R
|
Nov/Dec 2008 |
514-523 |
Buy |
| PostScription: Supporting Compounding Around the World |
Allen Loyd V Jr
|
Nov/Dec 2008 |
565 |
Buy |
| PreScription: First Estriol, Then What? |
Allen Loyd V Jr
|
Jul/Aug 2008 |
284 |
Buy |
| Lack of Commercial Oral Drug Formulations for Children in Two Hospital Group Purchasing Agreements in France and Canada |
Prot-Labarthe Sonia, Bussieres Jean-Francois, Barett Pierre, Bourdon Olivier, Brion Francoise
|
Jul/Aug 2008 |
365-367 |
Buy |
| PostScription: It Is Not Just What You Say…But How You Say It! |
Reed-Kane Dana
|
Jul/Aug 2008 |
375 |
Buy |
| Estriol: Women's Choice vs. A Manufacturer's Greed |
Goodrum Jennifer
|
Jul/Aug 2008 |
286-292 |
Buy |
| Recommendations for Overcoming Barriers to Medication Therapy Management Implementation, Part 1: Review of Literature |
Fyke Jeremy P, Yale Robert N, Corbett Corinne, Litera Natalie
|
Jul/Aug 2008 |
329-333 |
Buy |
| Using Readily Available Technology to Start or Enhance Pharmacy-Based Immunization |
Westrick Salisa C, Felkey Bill G
|
Jul/Aug 2008 |
334-337 |
Buy |
| PreScription: Pain! |
Allen Loyd V Jr
|
May/Jun 2008 |
180 |
Buy |
| Litigating the Legality of Compounding: The Medical Center Pharmacy Case |
Gibbs Jeffrey N
|
May/Jun 2008 |
238-241 |
Buy |
| Current Compounding Practices in Europe |
Carvalho Maria, Tuleu Catherine, Taylor Kevin MG
|
Mar/Apr 2008 |
94-99 |
Buy |
| Compounding Around the World |
Vail Jane
|
Mar/Apr 2008 |
102-115 |
Buy |
| Establishing a Quality-Assurance Program for Hospital Compounding |
McElhiney Linda F
|
Mar/Apr 2008 |
116-120 |
Buy |
| Hormone Therapy: It's Time for a Second Opinion |
Collins Joseph J, Ahlgrimm Maria
|
Mar/Apr 2008 |
122-127 |
Buy |
| PostScription: Accreditation by the Pharmacy Compounding Accreditation Board: Raising the Bar for Patient Care |
Murry Tom
|
Mar/Apr 2008 |
174-175 |
Buy |
| PreScription: Year Number 12…And Still Much Work to Do |
Allen Loyd V Jr
|
Jan/Feb 2008 |
4 |
Buy |
| Disposing of Expired Drugs and Chemicals: New Options for Compounders |
Vail Jane
|
Jan/Feb 2008 |
38-47 |
View Sample |
| Standard Operating Procedure: Compliance with the Health Insurance Portability and Accountability Act (HIPAA) of 1996 |
Allen Loyd V Jr
|
Jan/Feb 2008 |
63 |
Buy |
| Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 5: Verification of Accuracy, Sterility, and Sterilization of Compounded Preparations |
Allen Loyd V Jr, Okeke Claudia C
|
Jan/Feb 2008 |
54-60 |
Buy |
| Specialty Compounding for Improved Patient Care: 2006 National Survey of Compounding Pharmacists |
Huffman DC, Holmes Erin R
|
Jan/Feb 2008 |
74-82 |
Buy |
| Achievement of USP Chapter <797> Compliance by a 35-Bed Rural Hospital: A Case Study |
Peters Gregory F, McKeon Marghi R, Nerbun Richard G
|
Nov/Dec 2007 |
450-470 |
Buy |
| Quality-Control Analytical Methods: In-House Quality Control of Simple Compounds |
Trusley Craig
|
Nov/Dec 2007 |
487-490 |
Buy |
| PostScription: Thousands of Unapproved New Drugs are on the U.S. Market, Part 2 |
Allen Loyd V Jr
|
Sep/Oct 2007 |
438-439 |
Buy |
| PreScription: Bias, NAMS, and HRT |
Allen Loyd V Jr
|
Jul/Aug 2007 |
266 |
Buy |
| Correcting Misconceptions about Compounding Bioidentical Hormones: A Review of the Literature |
Paoletti Jim, Kaul Monica, Kloesel Lawson G
|
Jul/Aug 2007 |
269-272 |
Buy |
| Premarin: The Intriguing History of a Controversial Drug |
Vance Dwight A
|
Jul/Aug 2007 |
282-286 |
Buy |
| The Politics of Hormone Replacement Therapy |
Allen Loyd V Jr
|
Jul/Aug 2007 |
278-281 |
Buy |
| Quality-control Analytical Methods: Logbooks and Documentation Forms |
Allen Loyd V Jr
|
Jul/Aug 2007 |
306-311 |
Buy |
| Basics of Compounding: The Responsibilities of Compounding Personnel in Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 2 |
Allen Loyd V Jr, Okeke Claudia C
|
Jul/Aug 2007 |
314-323 |
Buy |
| Standard Operating Procedure: U.S. Food and Drug Administration Inspection--Releasing a Sample to the U.S. Food and Drug Administration |
Kupiec Tom, Kemp Jesse
|
Jul/Aug 2007 |
326-327 |
Buy |
| Statistical Analysis of Barrier Isolator/Glovebox Glove Failure |
Park Young H, Pines E, Ofouku M, Cournoyer ME
|
Jul/Aug 2007 |
338-346 |
Buy |
| PostScription: Thousands of Unapproved New Drugs are on the U.S. Market, Part 1 |
Allen Loyd V Jr
|
Jul/Aug 2007 |
350-351 |
Buy |
| Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development--Pediatric Formulations Initiative, Part 2 |
Giacoia George P, Taylor-Zapata Perdita, Mattison Donald
|
May/Jun 2007 |
220-225 |
Buy |
| Basics of Compounding for the Implementation of United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 1 |
Allen Loyd V Jr, Okeke Claudia C
|
May/Jun 2007 |
230-236 |
Buy |
| Standard Operating Procedure: Basic Compounding Documentation--the Master Formula Form |
Allen Loyd V Jr
|
May/Jun 2007 |
240-241 |
Buy |
| PostScription: Lobbying: How It Affects Compounding |
Rock Jim
|
May/Jun 2007 |
262-263 |
Buy |
| PreScription: State or Federal Control of Pharmacy Practice |
Allen Loyd V Jr
|
May/Jun 2007 |
178 |
Buy |
| PreScription: Putting the Science Back into Pharmacy |
Allen Loyd V Jr
|
Mar/Apr 2007 |
92 |
Buy |
| Certified Diabetes Educator: A Credential for Compounding Pharmacists |
Allen Loyd V Jr
|
Mar/Apr 2007 |
113-115 |
Buy |
| Records and Record-Keeping for the Hospital Compounding Pharmacist |
McElhiney Linda F
|
Mar/Apr 2007 |
138-143 |
Buy |
| PreScription: IJPC: The Next 10 Years |
Allen Loyd V Jr
|
Jan/Feb 2007 |
2 |
Buy |
| Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development—Pediatric Formulations Initiative, Part 1 |
Giacoia George P, Taylor-Zapata Perdita, Mattison Donald
|
Jan/Feb 2007 |
5-8 |
Buy |
| Collaborative Drug Therapy Management and its Application to Pharmaceutical Compounding |
Anderson Derick
|
Jan/Feb 2007 |
56-58 |
Buy |
| Pharmacogenomics: The End of Trial-and-Error Medicine? |
Vail Jane
|
Jan/Feb 2007 |
59-65 |
Buy |
| PostScription: Challenges Facing an Analytical Laboratory |
Kupiec Thomas C
|
Nov/Dec 2006 |
479-480 |
Buy |
| Specialty Compounding for Improved Patient Care: A National Survey of Compounding Pharmacists |
Huffman DC, Holmes Erin R
|
Nov/Dec 2006 |
462-468 |
Buy |
| Basics of Compounding for Hazardous Drugs, Part 2: Regulation and Sources of Contamination |
Allen Loyd V Jr
|
Nov/Dec 2006 |
446-448 |
Buy |
| Topical Cidofovir for Treatment of Resistant Viral Infections |
McElhiney Linda F
|
Sep/Oct 2006 |
324-328 |
Buy |
| Education, Training, and Evaluation of Hospital Compounding Personnel |
McElhiney Linda F
|
Sep/Oct 2006 |
361-368 |
Buy |
| Basics of Compounding for Hazardous Drugs, Part 1: An Introduction |
Allen Loyd V Jr
|
Sep/Oct 2006 |
377-379 |
Buy |
| PreScription: Standards, Legal Standards, and Accreditation |
|
May/Jun 2006 |
162 |
Buy |
| Prevention of Preterm Delivery with Compounded 17a-Hydroxyprogesterone Caproate |
Reed-Kane Dana, Kirshbaum Karen
|
May/Jun 2006 |
165-171 |
Buy |
| The Role of Drug Promotion in the Prescription of Hormone Replacement Therapy in the United States |
Stephenson Kenna, Jones William, Stephenson Douglas M M
|
May/Jun 2006 |
175-183 |
Buy |
| Quality-Control Analytical Methods: Particulate Matter in Injections: What is It and What are the Concerns? |
Tran Tuan, Kupiec Thomas C, Trissel Lawrence A
|
May/Jun 2006 |
202-204 |
Buy |
| Controlled Environment Testing Association Applications Guide for the Use of Barrier Isolators in Compounding Sterile Preparations in Healthcare Facilities, Part 2 |
Wagner James T
|
May/Jun 2006 |
208-211 |
Buy |
| PostScription: Tempted to Bill Compounds to Third-Party Cards? Don't Put Your Reimbursement or Contract at Risk! |
Mason Dave
|
May/Jun 2006 |
240 |
Buy |
| PreScription: The Squeaky Wheel Gets the Grease! |
Allen Loyd V Jr
|
Mar/Apr 2006 |
82 |
Buy |
| Is Your Cleanroom Clean? An In-depth Look at Cleaning and Disinfecting Agents, Procedures, and Requirements for the Compounding Pharmacist |
Jeffrey Megan
|
Mar/Apr 2006 |
113-119 |
Buy |
| Pharmaceutical Legislation: An Historical Perspective |
Worthen Dennis B
|
Jan/Feb 2006 |
20-28 |
Buy |
| Pharmacy Compounding Urban Legends |
Kastango Eric S
|
Jan/Feb 2006 |
32-34 |
Buy |
| Prescription: Pediatric Formulation Initiatives |
Allen Loyd V Jr
|
Nov/Dec 2005 |
410 |
Buy |
| Book Reviews: Lawsuit Lottery: The Hijacking of Justice in America |
Reed-Kane Dana
|
Sep/Oct 2005 |
332-333 |
Buy |
| Compounding: A Well-established Practice in 1938 |
Houck Larry K
|
Sep/Oct 2005 |
364-367 |
Buy |
| Local Ventilation for Safe Containment in the Pharmaceutical Industry |
Walters Douglas B, Ryan Ray
|
Jul/Aug 2005 |
293-298 |
Buy |
| Considerations for Choosing a Primary Engineering Control for Compounding Sterile Products |
Wagner James T
|
Jul/Aug 2005 |
284-290 |
Buy |
| Survey of State Veterinary Compounding Laws and Regulations |
Goodrum Jennifer
|
May/Jun 2005 |
209-211 |
Buy |
| PostScription: AVMA's Position on Compounding for Animals |
Riddell M Gatz
|
May/Jun 2005 |
247-248 |
Buy |
| Book Review: Miracle Cure: How to Solve America's Health Care Crisis and Why Canada Isn't the Answer |
Reed-Kane Dana
|
Mar/Apr 2005 |
93-94 |
Buy |
| Standard Operating Procedure: SOP Master Book--Maintenance |
Allen Loyd V Jr
|
Mar/Apr 2005 |
145 |
Buy |
| Proposed Revisions to USP Chapter <797> Pharmaceutical Compounding--Sterile Preparations |
Newton David W
|
Mar/Apr 2005 |
127-130 |
Buy |
| Quality-Control Analytical Methods: Chemical Testing Aspects of USP <797> for Compounded Sterile Preparations |
Kupiec Thomas C
|
Mar/Apr 2005 |
136-138 |
Buy |
| PostScription: Experts Everywhere |
Rahe Hank
|
Mar/Apr 2005 |
167 |
Buy |
| The US FDA List of Drugs Not to Be Used in Compounded Medications for Humans (the "Negative List") |
Allen Loyd V Jr, Ashworth Lisa D
|
Jan/Feb 2005 |
44-46 |
Buy |
| Is Veterinary Compounding Illegal Under Federal Law? |
Gibbs Jeffrey N
|
Nov/Dec 2004 |
449-450 |
Buy |
| PostScription: Your voice is important to the future of pharmacy |
Tosh Erik
|
Sep/Oct 2004 |
407 |
Buy |
| A Primer on USP Chapter 797, "Pharmaceutical Compounding - Sterile Preparations," and USP Process for Drug and Practice Standards |
Newton David W, Trissel Lawrence A
|
Jul/Aug 2004 |
251-263 |
Buy |
| PostScription: Cleanroom Standards |
Fitzpatrick Mike, Goldstein Ken
|
Mar/Apr 2004 |
160 |
Buy |
| PostScription: The Wedgewood Case: What It Means for Pharmacies |
Gibbs Jeffrey N, Wasserstein Jeffrey N
|
Jan/Feb 2004 |
79-80 |
Buy |
| PreScription: Take Care with Terminology for Altered- and Slow-release Formulations |
Allen Loyd V Jr
|
Nov/Dec 2003 |
418 |
Buy |
| PostScription: Changing Pharmacy Regulations Could Affect US Compounders |
Downing Pat, Roberson Kim
|
Nov/Dec 2003 |
495 |
Buy |
| Application of USP-NF Standards to Pharmacy Compounding |
Bormel Gail, Valentine Joseph G, Williams Roger L
|
Sep/Oct 2003 |
361-363 |
View Sample |
| Application of USP-NF Standards to Pharmacy Compounding |
Bormel Gail, Valentine Joseph G, Williams Roger L
|
Sep/Oct 2003 |
361-363 |
View Sample |
| HIPAA Privacy and Security for Providers: The Basics |
Kuruc Jullian H
|
Jul/Aug 2003 |
277-279 |
Buy |
| Containment of Hazardous Particulates in the Compounding Pharmacy |
Allen Loyd V Jr
|
Jul/Aug 2003 |
281-285 |
Buy |
| Postcription: Does Your Pharmacy Practice Follow the Pharmacist Code of Ethics? |
McElhiney Linda F
|
Jul/Aug 2003 |
320 |
Buy |
| Legal & Ethical Issues for Pharmacy Websites |
King LD, Brashares Jennifer
|
Mar/Apr 2003 |
88-92 |
Buy |
| Regulatory and Operational Issues of Founding a Compounding Pharmacy |
Smith Lisa K
|
Nov/Dec 2002 |
434-437 |
Buy |
| Medications Discontinued in the United States |
Ashworth Lisa D
|
Nov/Dec 2002 |
441-442 |
Buy |
| Compounding and the Courts |
Gibbs Jeffrey N, Wasserstein Jeffrey N
|
Jul/Aug 2002 |
263-266 |
Buy |
| Facilities and Procedures for Compounding Hazardous Drugs |
Rahe Hank
|
Jul/Aug 2002 |
267-270 |
Buy |
| Gaining Access to Investigational Drug for Treatment: An Investigational New Drug Application Primer |
Kramer Mark A, Grilley Bambi J
|
Jul/Aug 2002 |
271-273 |
Buy |
| Legal Issues: Technicians in the Compounding Pharmacy Practice |
Fix Jennifer Taylor
|
Jul/Aug 2002 |
274-275 |
Buy |
| Medications Discontinued in the United States |
Ashworth Lisa D
|
Jul/Aug 2002 |
286-287 |
Buy |
| Medications Discontinued in the United States |
Ashworth Lisa D
|
May/Jun 2002 |
193 |
Buy |
| Medications Discontinued in the United States |
Ashworth Lisa D
|
Mar/Apr 2002 |
123 |
Buy |
| Standard Operating Procedure: Evaluating and Selecting an Analytical Testing Laboratory |
Ashworth Lisa D, Gordon Dana, Leiter Charles W, Snow Whit
|
Mar/Apr 2002 |
149-150 |
Buy |
| Compounding with Controlled Substances |
Whalen Mary Kate
|
Jan/Feb 2002 |
8-10 |
Buy |
| The Problem of Drug Diversion |
Burke John J
|
Jan/Feb 2002 |
11-12 |
Buy |
| Providing Analgesia and Curtailing Drug Diversion: A Pharmacist's Perspective |
Vail Jane
|
Jan/Feb 2002 |
13-15 |
Buy |
| PostScription: Regulatory Uncertainty Requires Professional Responsibility |
King LD
|
Jan/Feb 2002 |
80 |
Buy |
| Compounding Issues and Accreditation Agencies |
Petroff Barb
|
Jul/Aug 2001 |
273-274 |
Buy |
| The American Veterinary Medical Association Compounding Position Statement |
Davidson Gigi S
|
May/Jun 2001 |
216-217 |
Buy |
| Establishing and Maintaining a Compounding Pharmacy Reference Library |
Allen Loyd V Jr
|
May/Jun 2001 |
226-227 |
Buy |
| Regulatory Issues for the Use of Bulk Drugs in Veterinary Compounding |
Chan Debora Schotik
|
Mar/Apr 2001 |
97-100 |
Buy |
| Drugs Banned for Use in Food Animals: An Explanation |
Davidson Gigi S
|
Mar/Apr 2001 |
101-103 |
Buy |
| From Wagon-Era Paregoric to Computer-Era Herbals |
Newton David W
|
Mar/Apr 2001 |
112-115 |
Buy |
| Consolidation of Pharmacy Compounding Services: An Alternative to Outsourcing |
Douglass Kate, Kastango Eric S
|
Mar/Apr 2001 |
140-144 |
Buy |
| Assignment of a Beyond-Use Date for Compounded Preparations |
Allen Loyd V Jr
|
Nov/Dec 2000 |
474-475 |
Buy |
| Compounding Using Hazardous Drugs |
Lau Kellie
|
Jul/Aug 2000 |
261-263 |
Buy |
| Compounding OTC Drugs: A Legal Perspective |
Gibbs Jeffrey N, Mazan Kate Duffy
|
May/Jun 2000 |
180-181 |
Buy |
| Pharmacy Licensure Requirements |
Allen Loyd V Jr
|
May/Jun 2000 |
186 |
Buy |
| The Future of Compounding: An Industry Perspective |
Capps Shelly, Winckler Susan C, Anthony Calvin J, Halperin Jerome A
|
May/Jun 2000 |
204-205 |
Buy |
| Assignment of Beyond-Use Dates |
Allen Loyd V Jr
|
May/Jun 2000 |
222 |
Buy |
| Analytical Testing of Extemporaneously Compounded Preparations |
Kupiec Thomas C
|
Mar/Apr 2000 |
105-107 |
Buy |
| When Problem Audits Strike |
Heckman H Edward
|
Nov/Dec 1999 |
458-459 |
Buy |
| When is Compounding for Animals Legal? |
Siegner A Wes Jr
|
May/Jun 1999 |
188-191 |
Buy |
| Report: USP Expert Advisory Panel on Pharmacy Compounding Practices |
Allen Loyd V Jr
|
Mar/Apr 1999 |
126-127 |
Buy |
| FDAMA Proposed List of Agents Not to be Compounded due to Withdrawal for Safety/Efficacy Concerns |
Allen Loyd V Jr
|
Jan/Feb 1999 |
25-29 |
Buy |
| Opioids for Noncancer Pain: From Controversy to Consensus |
Spanos Alan
|
Mar/Apr 1998 |
106-108 |
Buy |
| Firing an Employee - Without Getting Burned |
Davis Jeanie Lerche
|
Mar/Apr 1998 |
130-133 |
Buy |
| FDA and the Practice of Pharmacy: Regulatory Aspects of Compounding |
Letendre William R
|
Nov/Dec 1997 |
399-403 |
Buy |
| Aspirin in Chloroform (Chloroform Banned in US) |
Allen Loyd V Jr
|
Nov/Dec 1997 |
407 |
Buy |
| The Decision to Compound |
Allen Loyd V Jr
|
Mar/Apr 1997 |
71-74 |
Buy |
| The Compounding Pharmacist |
Allen Loyd V Jr
|
Mar/Apr 1997 |
73-74 |
Buy |
| NABP Guidelines: Good Compounding Practices Applicable to State-Licensed Pharmacies |
Allen Loyd V Jr
|
Mar/Apr 1997 |
75-77 |
Buy |
